Developer docs
API playgroundTry for free, no card

Search company profiles

Batash Endoscopic Weight Loss

Full company profile

uuid000rh3c

Namestring
Batash Endoscopic Weight Loss
Legal namestring
Batash Endoscopic Weight Loss Center
Company typeenum
Private
Founded yearint
1992
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRego Park, United States
HQ citystring
Rego Park
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
endoscopic weight loss, non-surgical bariatric procedures, gastric balloon placement, endoscopic sleeve gastroplasty, medical weight management
Industry1 code
1Obesity Medicine & Weight Management
CodeHLAKADALPrimaryYes
NAICS code2 codes
  • Freestanding Ambulatory Surgical and Emergency Centers621493
  • Diet and Weight Reducing Centers812191
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Medical Weight Loss Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Endoscopic Weight Loss Procedures
TypeOne Time License
Description

One-time surgical fees for procedures including Suture Sculpt ESG, gastric balloons, and revision procedures. Fees vary by procedure type and are typically paid prior to or at time of service.

batashmedical.com
2Aesthetic Surgery Services
TypeOne Time License
Description

Surgical aesthetic procedures including liposuction, tummy tuck, breast augmentation, breast lift performed by Dr. Yoel Rojas at Batash Aesthetics.

batashmedical.com
3RX Weight Loss Program
TypeSubscription Recurring
Description

Monthly prescription weight loss medication programs including peptides and ongoing medical supervision.

batashmedical.com
4Financing Programs
TypeTransaction Fee
Description

Partnership with CareCredit, Alphaeon, and Cherry for patient financing, enabling monthly payment plans for procedures.

batashmedical.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details4 tiers
1Suture Sculpt ESG: Non-surgical endoscopic sleeve gastroplasty
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Approximately $11,000 out-of-pocket as mentioned in NY Post feature. Most insurance companies do not cover ESG procedures.

batashmedical.com
2Liposuction procedure
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

National average cost is $4,711 base excluding anesthesia, facility fees, and related expenses. Full cost provided during personal consultation.

batashmedical.com
3Tummy Tuck surgery
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Average cost in the United States ranges from $7,000 to $12,000 depending on type of tummy tuck, extent of correction needed, surgeon, and facility.

batashmedical.com
4Financing through Cherry
ModelSubscriptionBilling cadenceMonthly
Notes

0% APR options available for qualifying patients. Monthly payment plans with flexible terms. Quick application with no hard credit check.

batashmedical.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 4 records shown
1Suture Sculpt
Description

Endoscopic Sleeve Gastroplasty (ESG) procedure - a long-term non-surgical weight loss solution that reduces stomach size using sutures placed from inside without incisions.

batashmedical.com
+3 more records
Core offering1 text field

Batash Endoscopic Weight Loss provides non-surgical and minimally invasive endoscopic weight loss procedures, including the proprietary Suture Sculpt (ESG), Suture Resculpt (gastric bypass revision), and intragastric balloon systems (Orbera, Spatz3, Allurion). The practice also delivers supporting programs including a monthly RX Weight Loss subscription, Peptides RX, and a full suite of aesthetic services such as liposuction, tummy tuck, breast augmentation and lift, arm/thigh lift, mommy makeover, and BodyTite. Care is delivered on a same-day outpatient basis across two clinic locations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 28-30% total body weight loss with Suture Sculpt ESG procedure
+5 more records
Product overview1 text field

Batash Endoscopic Weight Loss Center operates as a medical practice offering a comprehensive portfolio of non-surgical and surgical weight loss and aesthetic procedures. The core offerings center on three primary endoscopic weight loss systems: the Suture Sculpt (Endoscopic Sleeve Gastroplasty/ESG) for long-term weight loss achieving 28-30% total body weight reduction, the Gastric Balloon Weight Loss System providing short-term 6-8 month solutions with 18-21% weight loss using Orbera, Spatz3, and Allurion balloons, and the Suture Resculpt for revision procedures. Supporting the core procedures, the practice offers medical weight loss programs including RX Weight Loss and Peptides RX. Under the Batash Aesthetics sub-brand, the practice provides surgical body contouring and cosmetic procedures including Liposuction, Tummy Tuck, Breast Augmentation, Breast Lift, Arm Lift, Thigh Lift, BodyTite, Mommy Makeover, and Facial Rejuvenation—all performed by Dr. Yoel Rojas. The practice operates from two locations in Queens, NY and Miami, FL.

Product and service2 records
1Suture Sculpt Weight Loss System (Endoscopic Sleeve Gastroplasty / ESG)
CategoryEndoscopic Weight Loss Procedure
Description

Non-surgical, incisionless endoscopic procedure that reduces stomach volume using internal suturing to achieve weight loss; designed for adults seeking an alternative to traditional bariatric surgery with 1-3 day recovery.

2Gastric Balloon Weight Loss System (Orbera, Spatz3, Allurion)
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Founded by Dr. Christopher McGowan, one of the most prolific ESG and endoscopic weight loss practitioners in the U.S. Operates clinics in North Carolina and offers the same core procedures (ESG, gastric balloons, bariatric endoscopy revisions) to a similar patient segment. The most direct clinical and operational comparable to Batash.

2New York Bariatric Group
TypeDirect peer
Description

Multi-location bariatric surgery and weight loss practice in the New York metro area offering gastric sleeve, gastric bypass, and LAP-BAND procedures. Targets the same BMI 25+ patient population in Batash's core geography with surgical alternatives — represents both a competitor and a referral source for complex cases.

TypeDirect peer
Description

Regional bariatric and weight loss practice serving New Jersey and the greater New York metro area. Offers surgical and non-surgical weight loss options targeting a similar affluent, health-conscious patient demographic in the Northeast corridor.

TypeDirect peer
Description

Dr. Christopher McGowan's brand and clinical platform for endoscopic bariatric procedures, including ESG and revision procedures. Directly comparable in clinical approach, patient demographic, and procedure mix to Batash's Suture Sculpt offerings.

TypeBroad incumbent
Description

Academic medical center offering comprehensive medical, endoscopic, and surgical weight management in New York City. Operates in the same metro as Batash's Queens headquarters with broader institutional infrastructure and insurance participation, representing a larger but less specialized competitor.

TypeBroad incumbent
Description

Academic medical center offering bariatric surgery and medical weight management programs in the New York metro area. Provides integrated care including insurance-covered surgical options that compete with Batash's cash-pay endoscopic approach on price for some patient segments.

TypeBroad incumbent
Description

Large academic medical center offering comprehensive bariatric surgery, endoscopic procedures, and medical weight management nationally. Represents the institutional incumbent model with insurance coverage and research-driven protocols that Batash competes against for complex and out-of-state patients.

TypeEmerging player
Description

Telehealth metabolic reset program combining GLP-1 medication prescribing with coaching. Targets the same BMI 25+ weight loss patient demographic through a virtual, lower-cost channel. Represents the most direct digital threat to cash-pay endoscopic procedures by offering accessible pharmacotherapy alternatives.

9Ro
TypeEmerging player
Description

Direct-to-consumer telehealth platform offering weight loss programs including GLP-1 prescriptions (Wegovy, Zepbound) at $145/month. Competes for the same price-sensitive patient segment with a fully virtual, lower-cost model and is rapidly scaling its obesity care vertical.

TypeEmerging player
Description

Telehealth weight management platform combining prescription medication (including GLP-1s) with personalized coaching. Targets the same patient demographic as Batash but through a virtual, primarily medication-driven care model that is cheaper and more accessible than endoscopic procedures.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Batash Endoscopic Weight Loss

Medical Weight Loss Servicesbatashmedical.com

Batash Endoscopic Weight Loss firmographics

Firmographics
Name
Batash Endoscopic Weight Loss
Legal name
Batash Endoscopic Weight Loss Center
Website
https://batashmedical.com
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Batash Endoscopic Weight Loss industry classification

Industry
Product category
Medical Weight Loss Services
NAICS
Freestanding Ambulatory Surgical and Emergency Centers (621493), Diet and Weight Reducing Centers (812191)
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro primary industry
Obesity Medicine & Weight Management (HLAKADAL)

Keywords

  • Endoscopic weight loss
  • Non-surgical bariatric procedures
  • Gastric balloon placement
  • Endoscopic sleeve gastroplasty
  • Medical weight management

Where Batash Endoscopic Weight Loss is headquartered

Location

Headquarters

HQ city
Rego Park
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Batash Endoscopic Weight Loss business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Endoscopic Weight Loss Procedures: One-time surgical fees for procedures including Suture Sculpt ESG, gastric balloons, and revision procedures. Fees vary by procedure type and are typically paid prior to or at time of service.
  2. Aesthetic Surgery Services: Surgical aesthetic procedures including liposuction, tummy tuck, breast augmentation, breast lift performed by Dr. Yoel Rojas at Batash Aesthetics.
  3. RX Weight Loss Program: Monthly prescription weight loss medication programs including peptides and ongoing medical supervision.
  4. Financing Programs: Partnership with CareCredit, Alphaeon, and Cherry for patient financing, enabling monthly payment plans for procedures.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goSuture Sculpt ESG: Non-surgical endoscopic sleeve gastroplasty
One time/ perpetual licensePay-as-you-goLiposuction procedure
One time/ perpetual licensePay-as-you-goTummy Tuck surgery
SubscriptionMonthlyFinancing through Cherry

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Batash Endoscopic Weight Loss product offering

Product offering

Core offering

Batash Endoscopic Weight Loss provides non-surgical and minimally invasive endoscopic weight loss procedures, including the proprietary Suture Sculpt (ESG), Suture Resculpt (gastric bypass revision), and intragastric balloon systems (Orbera, Spatz3, Allurion). The practice also delivers supporting programs including a monthly RX Weight Loss subscription, Peptides RX, and a full suite of aesthetic services such as liposuction, tummy tuck, breast augmentation and lift, arm/thigh lift, mommy makeover, and BodyTite. Care is delivered on a same-day outpatient basis across two clinic locations.

Product overview

Batash Endoscopic Weight Loss Center operates as a medical practice offering a comprehensive portfolio of non-surgical and surgical weight loss and aesthetic procedures. The core offerings center on three primary endoscopic weight loss systems: the Suture Sculpt (Endoscopic Sleeve Gastroplasty/ESG) for long-term weight loss achieving 28-30% total body weight reduction, the Gastric Balloon Weight Loss System providing short-term 6-8 month solutions with 18-21% weight loss using Orbera, Spatz3, and Allurion balloons, and the Suture Resculpt for revision procedures. Supporting the core procedures, the practice offers medical weight loss programs including RX Weight Loss and Peptides RX. Under the Batash Aesthetics sub-brand, the practice provides surgical body contouring and cosmetic procedures including Liposuction, Tummy Tuck, Breast Augmentation, Breast Lift, Arm Lift, Thigh Lift, BodyTite, Mommy Makeover, and Facial Rejuvenation—all performed by Dr. Yoel Rojas. The practice operates from two locations in Queens, NY and Miami, FL.

Differentiator

Problem solved

Functional benefit

Brands

  • Suture Sculpt: Endoscopic Sleeve Gastroplasty (ESG) procedure - a long-term non-surgical weight loss solution that reduces stomach size using sutures placed from inside without incisions.
  • Suture Resculpt
  • Gastric Balloon Weight Loss System
  • Batash Aesthetics

Products and services

  • Suture Sculpt Weight Loss System (Endoscopic Sleeve Gastroplasty / ESG) Non-surgical, incisionless endoscopic procedure that reduces stomach volume using internal suturing to achieve weight loss; designed for adults seeking an alternative to traditional bariatric surgery with 1-3 day recovery.
  • Gastric Balloon Weight Loss System (Orbera, Spatz3, Allurion)

Quantifiable outcome

  • 28-30% total body weight loss with Suture Sculpt ESG procedure
  • +5 more outcomes

Companies that use Batash Endoscopic Weight Loss

Customer profile

Named customers9 records

Segments3 records

Ideal customer profiles1 record

Batash Endoscopic Weight Loss technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature3 records

Batash Endoscopic Weight Loss partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Batash Endoscopic Weight Loss competitors and assessment

Company assessment

Direct peers

  • True You Weight Loss: Founded by Dr. Christopher McGowan, one of the most prolific ESG and endoscopic weight loss practitioners in the U.S. Operates clinics in North Carolina and offers the same core procedures (ESG, gastric balloons, bariatric endoscopy revisions) to a similar patient segment. The most direct clinical and operational comparable to Batash.
  • New York Bariatric Group: Multi-location bariatric surgery and weight loss practice in the New York metro area offering gastric sleeve, gastric bypass, and LAP-BAND procedures. Targets the same BMI 25+ patient population in Batash's core geography with surgical alternatives — represents both a competitor and a referral source for complex cases.
  • Princeton Center for Bariatric Surgery: Regional bariatric and weight loss practice serving New Jersey and the greater New York metro area. Offers surgical and non-surgical weight loss options targeting a similar affluent, health-conscious patient demographic in the Northeast corridor.
  • Endobariatric: Dr. Christopher McGowan's brand and clinical platform for endoscopic bariatric procedures, including ESG and revision procedures. Directly comparable in clinical approach, patient demographic, and procedure mix to Batash's Suture Sculpt offerings.

Broad incumbents

  • NYU Langone Weight Management Program: Academic medical center offering comprehensive medical, endoscopic, and surgical weight management in New York City. Operates in the same metro as Batash's Queens headquarters with broader institutional infrastructure and insurance participation, representing a larger but less specialized competitor.
  • Mount Sinai Weight Management: Academic medical center offering bariatric surgery and medical weight management programs in the New York metro area. Provides integrated care including insurance-covered surgical options that compete with Batash's cash-pay endoscopic approach on price for some patient segments.
  • Cleveland Clinic Bariatric and Metabolic Institute: Large academic medical center offering comprehensive bariatric surgery, endoscopic procedures, and medical weight management nationally. Represents the institutional incumbent model with insurance coverage and research-driven protocols that Batash competes against for complex and out-of-state patients.

Emerging players

  • Calibrate: Telehealth metabolic reset program combining GLP-1 medication prescribing with coaching. Targets the same BMI 25+ weight loss patient demographic through a virtual, lower-cost channel. Represents the most direct digital threat to cash-pay endoscopic procedures by offering accessible pharmacotherapy alternatives.
  • Ro: Direct-to-consumer telehealth platform offering weight loss programs including GLP-1 prescriptions (Wegovy, Zepbound) at $145/month. Competes for the same price-sensitive patient segment with a fully virtual, lower-cost model and is rapidly scaling its obesity care vertical.
  • Found: Telehealth weight management platform combining prescription medication (including GLP-1s) with personalized coaching. Targets the same patient demographic as Batash but through a virtual, primarily medication-driven care model that is cheaper and more accessible than endoscopic procedures.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Batash Endoscopic Weight Loss social profiles

Digital presence

Batash Endoscopic Weight Loss financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Batash Endoscopic Weight Loss leadership team

Management profile

Number of profiles

Profiles6 records

Batash Endoscopic Weight Loss funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Batash Endoscopic Weight Loss M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Batash Endoscopic Weight Loss

What does Batash Endoscopic Weight Loss do?

Batash Endoscopic Weight Loss provides non-surgical and minimally invasive endoscopic weight loss procedures, including the proprietary Suture Sculpt (ESG), Suture Resculpt (gastric bypass revision), and intragastric balloon systems (Orbera, Spatz3, Allurion). The practice also delivers supporting programs including a monthly RX Weight Loss subscription, Peptides RX, and a full suite of aesthetic services such as liposuction, tummy tuck, breast augmentation and lift, arm/thigh lift, mommy makeover, and BodyTite. Care is delivered on a same-day outpatient basis across two clinic locations.

Is Batash Endoscopic Weight Loss a public or private company?

Batash Endoscopic Weight Loss is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Batash Endoscopic Weight Loss founded?

Batash Endoscopic Weight Loss was founded in 1992. It employs 11 to 50 people.

Where is Batash Endoscopic Weight Loss based?

Batash Endoscopic Weight Loss is headquartered in Rego Park, United States, in the North America region.

How does Batash Endoscopic Weight Loss make money?

Four revenue lines are on record. Endoscopic Weight Loss Procedures are the primary driver. The others are aesthetic Surgery Services, RX Weight Loss Program and financing Programs.

Who are Batash Endoscopic Weight Loss's main competitors?

Direct peers on record are True You Weight Loss, New York Bariatric Group, Princeton Center for Bariatric Surgery and Endobariatric. Broad incumbents are NYU Langone Weight Management Program, Mount Sinai Weight Management and Cleveland Clinic Bariatric and Metabolic Institute. Emerging players are Calibrate, Ro and Found.

Does Batash Endoscopic Weight Loss have an API?

No public API is recorded for Batash Endoscopic Weight Loss.

What industry is Batash Endoscopic Weight Loss in?

Batash Endoscopic Weight Loss's product category is Medical Weight Loss Services. Its primary akta.pro industry code is HLAKADAL, Obesity Medicine & Weight Management. Its NAICS code is 621493 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales